ES2195171T3 - Sistema de transposicion in vitro usando transposasa tn5 modificada. - Google Patents

Sistema de transposicion in vitro usando transposasa tn5 modificada.

Info

Publication number
ES2195171T3
ES2195171T3 ES97940955T ES97940955T ES2195171T3 ES 2195171 T3 ES2195171 T3 ES 2195171T3 ES 97940955 T ES97940955 T ES 97940955T ES 97940955 T ES97940955 T ES 97940955T ES 2195171 T3 ES2195171 T3 ES 2195171T3
Authority
ES
Spain
Prior art keywords
transposase
modified
vitro transposition
transposition system
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97940955T
Other languages
English (en)
Inventor
William S Reznikoff
Igor Yu Goryshin
Hong Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/814,877 external-priority patent/US5965443A/en
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Application granted granted Critical
Publication of ES2195171T3 publication Critical patent/ES2195171T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/90Vectors containing a transposable element

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Control Of Eletrric Generators (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Power Steering Mechanism (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Other Liquid Machine Or Engine Such As Wave Power Use (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

LA INVENCION SE REFIERE A UN SISTEMA DE TRANSPOSICION IN VITRO QUE COMPRENDE UN ADN DONOR QUE CONTIENE UN ELEMENTO TRANSPOSABLE RODEADO POR UN PAR DE TRANSPOSONES TN5 BACTERIANOS EN EL EXTERIOR DE SECUENCIAS CON REPETICIONES TERMINALES, UN ADN OBJETIVO EN EL CUAL EL ELEMENTO TRANSPOSABLE PUEDE TRANSPONERSE, Y UNA TRANSPOSASA TN5 MODIFICADA QUE PRESENTA UNA AVIDEZ DE ENLACE SUPERIOR EN EL EXTERIOR DE LAS SECUENCIAS CON REPETICIONES TERMINALES Y MENOS SUSCEPTIBLE DE ADOPTAR UNA FORMA MULTIMERICA INACTIVA QUE LA TRANSPOSASA TN5 DE TIPO INCONTROLADA.
ES97940955T 1996-09-09 1997-09-09 Sistema de transposicion in vitro usando transposasa tn5 modificada. Expired - Lifetime ES2195171T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/814,877 US5965443A (en) 1996-09-09 1996-09-09 System for in vitro transposition
US08/850,880 US5925545A (en) 1996-09-09 1997-05-02 System for in vitro transposition

Publications (1)

Publication Number Publication Date
ES2195171T3 true ES2195171T3 (es) 2003-12-01

Family

ID=27123892

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97940955T Expired - Lifetime ES2195171T3 (es) 1996-09-09 1997-09-09 Sistema de transposicion in vitro usando transposasa tn5 modificada.

Country Status (12)

Country Link
US (3) US5925545A (es)
EP (1) EP0927258B1 (es)
JP (1) JP4361971B2 (es)
CN (1) CN1163605C (es)
AT (1) ATE238422T1 (es)
AU (1) AU732130B2 (es)
CA (1) CA2265477C (es)
DE (1) DE69721282T2 (es)
ES (1) ES2195171T3 (es)
PL (1) PL193220B1 (es)
RU (1) RU2218406C2 (es)
WO (1) WO1998010077A1 (es)

Families Citing this family (131)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925545A (en) * 1996-09-09 1999-07-20 Wisconsin Alumni Research Foundation System for in vitro transposition
US6022716A (en) 1998-04-10 2000-02-08 Genset Sa High throughput DNA sequencing vector
US6159736A (en) * 1998-09-23 2000-12-12 Wisconsin Alumni Research Foundation Method for making insertional mutations using a Tn5 synaptic complex
US6299850B1 (en) 1999-03-16 2001-10-09 The United States Of America As Represented By The Department Of Energy Carbon activation process for increased surface accessibility in electrochemical capacitors
US6562624B2 (en) 1999-03-17 2003-05-13 Paradigm Genetics, Inc. Methods and materials for the rapid and high volume production of a gene knock-out library in an organism
EP1161551A2 (en) * 1999-03-17 2001-12-12 Paradigm Genetics Inc. Methods and materials for the rapid and high volume production of a gene knock-out library in an organism
US6818441B1 (en) * 1999-06-18 2004-11-16 Aventis Pharmaceuticals Inc. Vectors for improving cloning and expression in low copy number plasmids
US6406896B1 (en) * 1999-08-02 2002-06-18 Wisconsin Alumni Research Foundation Transposase enzyme and method for use
US7029842B2 (en) * 2000-04-07 2006-04-18 Novozymes A/S Signal sequence trapping
AU2001271912A1 (en) * 2000-07-07 2002-01-21 Maxygen, Inc. Molecular breeding of transposable elements
EP1339863A2 (en) * 2000-12-05 2003-09-03 Wisconsin Alumni Research Foundation Double transposition methods for manipulating nucleic acids
US7138267B1 (en) * 2001-04-04 2006-11-21 Epicentre Technologies Corporation Methods and compositions for amplifying DNA clone copy number
US7262056B2 (en) * 2001-11-08 2007-08-28 Mirus Bio Corporation Enhancing intermolecular integration of nucleic acids using integrator complexes
KR100459870B1 (ko) * 2002-02-22 2004-12-04 한국과학기술원 트랜스포존과 Cre/loxP 부위 특이적 재조합 방법을 이용하는 염색체의 특정부위가 제거된 미생물 변이주 제조방법
FI20020746A7 (fi) * 2002-04-18 2003-10-19 Finnzymes Oy Menetelmä ja materiaalit polypeptidien deleetiojohdannaisten tuottamiseksi
US20040235011A1 (en) * 2002-06-26 2004-11-25 Cooper Richard K. Production of multimeric proteins
US7527966B2 (en) * 2002-06-26 2009-05-05 Transgenrx, Inc. Gene regulation in transgenic animals using a transposon-based vector
US20040172667A1 (en) * 2002-06-26 2004-09-02 Cooper Richard K. Administration of transposon-based vectors to reproductive organs
US7316903B2 (en) * 2003-03-28 2008-01-08 United States Of America As Represented By The Department Of Health And Human Services Detection of nucleic acid sequence variations using phase Mu transposase
WO2004093645A2 (en) * 2003-04-17 2004-11-04 Wisconsin Alumni Research Foundation Tn5 transposase mutants and the use thereof
US8071364B2 (en) * 2003-12-24 2011-12-06 Transgenrx, Inc. Gene therapy using transposon-based vectors
US20050214838A1 (en) * 2004-03-10 2005-09-29 Waclaw Szybalski Methods for mapping and sequencing nucleic acids
WO2005100585A2 (en) 2004-03-30 2005-10-27 Epicentre Methods for obtaining directionally truncated polypeptides
US20060294606A1 (en) * 2004-05-18 2006-12-28 Istefo Moisyadi Tn5 transposase-mediated transgenesis
US7608434B2 (en) * 2004-08-04 2009-10-27 Wisconsin Alumni Research Foundation Mutated Tn5 transposase proteins and the use thereof
US8383345B2 (en) 2008-09-12 2013-02-26 University Of Washington Sequence tag directed subassembly of short sequencing reads into long sequencing reads
WO2010036978A2 (en) * 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of growth hormone
WO2010036976A2 (en) * 2008-09-25 2010-04-01 Transgenrx, Inc. Novel vectors for production of antibodies
EP2342224A2 (en) * 2008-09-25 2011-07-13 TransGenRx, Inc. Novel vectors for production of interferon
ES2743029T3 (es) * 2008-10-24 2020-02-18 Epicentre Tech Corporation Composiciones de extremo del transposón y métodos para modificar ácidos nucleicos
US9080211B2 (en) 2008-10-24 2015-07-14 Epicentre Technologies Corporation Transposon end compositions and methods for modifying nucleic acids
WO2010118360A1 (en) * 2009-04-09 2010-10-14 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Production of proteins using transposon-based vectors
AU2011237729B2 (en) 2010-04-05 2014-04-03 Prognosys Biosciences, Inc. Spatially encoded biological assays
US10787701B2 (en) 2010-04-05 2020-09-29 Prognosys Biosciences, Inc. Spatially encoded biological assays
US20190300945A1 (en) 2010-04-05 2019-10-03 Prognosys Biosciences, Inc. Spatially Encoded Biological Assays
US9353412B2 (en) 2010-06-18 2016-05-31 Illumina, Inc. Conformational probes and methods for sequencing nucleic acids
US9074251B2 (en) 2011-02-10 2015-07-07 Illumina, Inc. Linking sequence reads using paired code tags
US8829171B2 (en) 2011-02-10 2014-09-09 Illumina, Inc. Linking sequence reads using paired code tags
WO2012103545A1 (en) 2011-01-28 2012-08-02 Illumina, Inc. Oligonucleotide replacement for di-tagged and directional libraries
WO2012106546A2 (en) 2011-02-02 2012-08-09 University Of Washington Through Its Center For Commercialization Massively parallel continguity mapping
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
US20150284768A1 (en) * 2012-05-29 2015-10-08 The Johns Hopkins University Eukaryotic transposase mutants and transposon end compositions for modifying nucleic acids and methods for production and use in the generation of sequencing libraries
US9593365B2 (en) 2012-10-17 2017-03-14 Spatial Transcriptions Ab Methods and product for optimising localised or spatial detection of gene expression in a tissue sample
US9683230B2 (en) 2013-01-09 2017-06-20 Illumina Cambridge Limited Sample preparation on a solid support
EP3553175B1 (en) 2013-03-13 2021-07-14 Illumina, Inc. Method of preparing a nucleic acid sequencing library
DK3013983T3 (da) 2013-06-25 2023-03-06 Prognosys Biosciences Inc Spatialt kodede biologiske assays ved brug af en mikrofluidisk anordning
EP3066114B1 (en) 2013-11-07 2019-11-13 Agilent Technologies, Inc. Plurality of transposase adapters for dna manipulations
US10246746B2 (en) 2013-12-20 2019-04-02 Illumina, Inc. Preserving genomic connectivity information in fragmented genomic DNA samples
EP3105349B1 (en) 2014-02-11 2020-07-15 F. Hoffmann-La Roche AG Targeted sequencing and uid filtering
CA3262557A1 (en) * 2014-04-15 2026-03-02 Illumina, Inc. Modified transposases for improved insertion sequence bias and increased dna input tolerance
WO2015189636A1 (en) 2014-06-13 2015-12-17 Illumina Cambridge Limited Methods and compositions for preparing sequencing libraries
WO2016003814A1 (en) 2014-06-30 2016-01-07 Illumina, Inc. Methods and compositions using one-sided transposition
JP6808617B2 (ja) 2014-10-17 2021-01-06 イルミナ ケンブリッジ リミテッド 連続性を維持した転位
DK3222717T3 (da) * 2014-11-18 2020-06-29 Oriciro Genomics Inc Fremgangsmåde til at amplificere cirkulært dna
EP3259355B1 (en) 2015-02-20 2020-11-25 The Regents of the University of California Methods related to dna sequencing
CA2977818A1 (en) 2015-03-11 2016-09-15 Board Of Regents, The University Of Texas System Transposase polypeptides and uses thereof
CN120425026A (zh) 2015-04-10 2025-08-05 十程基因技术瑞典公司 生物样本的空间区别、多重核酸分析
US10156025B2 (en) 2015-05-04 2018-12-18 University Of South Carolina Monolithic heterogeneous single crystals with multiple regimes for solid state laser applications
EP4603581A3 (en) 2015-05-28 2025-11-12 Illumina Cambridge Limited Surface-based tagmentation
WO2016196358A1 (en) 2015-05-29 2016-12-08 Epicentre Technologies Corporation Methods of analyzing nucleic acids
CA2992717A1 (en) 2015-07-17 2017-01-26 President And Fellows Of Harvard College Methods of amplifying nucleic acid sequences
SI3334841T1 (sl) 2015-08-12 2020-03-31 Cemm - Forschungszentrum Fuer Molekulare Medizin Gmbh Postopki za proučevanje nukleinskih kislin
WO2018013710A1 (en) 2016-07-12 2018-01-18 F. Hoffman-La Roche Ag Primer extension target enrichment
WO2018027048A1 (en) 2016-08-05 2018-02-08 Bio-Rad Laboratories, Inc. Second strand direct
WO2018118971A1 (en) 2016-12-19 2018-06-28 Bio-Rad Laboratories, Inc. Droplet tagging contiguity preserved tagmented dna
CN106754811B (zh) * 2016-12-21 2019-05-14 南京诺唯赞生物科技有限公司 一种突变型Tn5转座酶及其制备方法和应用
CN108265101A (zh) * 2016-12-30 2018-07-10 天津强微特生物科技有限公司 一种快速稳定的Tn5转座酶酶活测定方法
FI3452621T3 (fi) 2017-02-21 2022-12-15 Tagmentaatio käyttäen immobilisoituja transposomeja linkkereillä
WO2019060907A1 (en) 2017-09-25 2019-03-28 Fred Hutchinson Cancer Research Center HIGH PERFORMANCE TARGETED IN SITU PANGENOMIC PROFILING
US11732257B2 (en) 2017-10-23 2023-08-22 Massachusetts Institute Of Technology Single cell sequencing libraries of genomic transcript regions of interest in proximity to barcodes, and genotyping of said libraries
US10907205B2 (en) 2017-11-02 2021-02-02 Bio-Rad Laboratories, Inc. Transposase-based genomic analysis
CN113166807B (zh) 2018-08-20 2024-06-04 生物辐射实验室股份有限公司 通过分区中条码珠共定位生成核苷酸序列
EP4603594A3 (en) 2018-08-28 2025-11-12 10X Genomics, Inc. Increasing spatial array resolution
US11519033B2 (en) 2018-08-28 2022-12-06 10X Genomics, Inc. Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample
MX2021003771A (es) 2018-11-30 2021-05-27 Illumina Inc Analisis de analitos multiples usando un ensayo unico.
US20220290217A1 (en) 2018-12-10 2022-09-15 10X Genomics, Inc. Resolving spatial arrays using deconvolution
US12529094B2 (en) 2018-12-10 2026-01-20 10X Genomics, Inc. Imaging system hardware
CA3115155A1 (en) 2018-12-17 2020-06-25 Illumina, Inc. Methods and means for preparing a library for sequencing
US11926867B2 (en) 2019-01-06 2024-03-12 10X Genomics, Inc. Generating capture probes for spatial analysis
US11649485B2 (en) 2019-01-06 2023-05-16 10X Genomics, Inc. Generating capture probes for spatial analysis
EP3976820A1 (en) 2019-05-30 2022-04-06 10X Genomics, Inc. Methods of detecting spatial heterogeneity of a biological sample
AU2020312787A1 (en) 2019-07-12 2021-06-17 Illumina Cambridge Limited Nucleic acid library preparation using electrophoresis
AU2020342793A1 (en) 2019-09-06 2022-04-21 Cemm - Forschungszentrum Für Molekulare Medizin Gmbh Method for sequencing RNA oligonucleotides
US12297426B2 (en) 2019-10-01 2025-05-13 The Broad Institute, Inc. DNA damage response signature guided rational design of CRISPR-based systems and therapies
JP7489455B2 (ja) 2019-10-25 2024-05-23 チャンピン ナショナル ラボラトリー 哺乳類dnaのメチル化の検出及び分析
WO2021092433A2 (en) 2019-11-08 2021-05-14 10X Genomics, Inc. Enhancing specificity of analyte binding
EP4081777B1 (en) 2019-12-23 2026-02-18 10X Genomics, Inc. Reversible fixing reagents and methods of use thereof
EP4081656A1 (en) 2019-12-23 2022-11-02 10X Genomics, Inc. Compositions and methods for using fixed biological samples in partition-based assays
CN121022991A (zh) 2019-12-23 2025-11-28 10X基因组学有限公司 使用rna模板化连接进行空间分析的方法
US12365942B2 (en) 2020-01-13 2025-07-22 10X Genomics, Inc. Methods of decreasing background on a spatial array
US12405264B2 (en) 2020-01-17 2025-09-02 10X Genomics, Inc. Electrophoretic system and method for analyte capture
US11732299B2 (en) 2020-01-21 2023-08-22 10X Genomics, Inc. Spatial assays with perturbed cells
US11702693B2 (en) 2020-01-21 2023-07-18 10X Genomics, Inc. Methods for printing cells and generating arrays of barcoded cells
US20210230681A1 (en) 2020-01-24 2021-07-29 10X Genomics, Inc. Methods for spatial analysis using proximity ligation
US12076701B2 (en) 2020-01-31 2024-09-03 10X Genomics, Inc. Capturing oligonucleotides in spatial transcriptomics
US12110541B2 (en) 2020-02-03 2024-10-08 10X Genomics, Inc. Methods for preparing high-resolution spatial arrays
US11898205B2 (en) 2020-02-03 2024-02-13 10X Genomics, Inc. Increasing capture efficiency of spatial assays
US11732300B2 (en) 2020-02-05 2023-08-22 10X Genomics, Inc. Increasing efficiency of spatial analysis in a biological sample
WO2021158925A1 (en) 2020-02-07 2021-08-12 10X Genomics, Inc. Quantitative and automated permeabilization performance evaluation for spatial transcriptomics
US12281357B1 (en) 2020-02-14 2025-04-22 10X Genomics, Inc. In situ spatial barcoding
US11891654B2 (en) 2020-02-24 2024-02-06 10X Genomics, Inc. Methods of making gene expression libraries
WO2021216708A1 (en) 2020-04-22 2021-10-28 10X Genomics, Inc. Methods for spatial analysis using targeted rna depletion
WO2021237087A1 (en) 2020-05-22 2021-11-25 10X Genomics, Inc. Spatial analysis to detect sequence variants
EP4414459B1 (en) 2020-05-22 2025-09-03 10X Genomics, Inc. Simultaneous spatio-temporal measurement of gene expression and cellular activity
WO2021242834A1 (en) 2020-05-26 2021-12-02 10X Genomics, Inc. Method for resetting an array
US12031177B1 (en) 2020-06-04 2024-07-09 10X Genomics, Inc. Methods of enhancing spatial resolution of transcripts
WO2021252499A1 (en) 2020-06-08 2021-12-16 10X Genomics, Inc. Methods of determining a surgical margin and methods of use thereof
EP4446430A3 (en) 2020-06-10 2024-12-18 10X Genomics, Inc. Methods for determining a location of an analyte in a biological sample
WO2021263111A1 (en) 2020-06-25 2021-12-30 10X Genomics, Inc. Spatial analysis of dna methylation
US12209280B1 (en) 2020-07-06 2025-01-28 10X Genomics, Inc. Methods of identifying abundance and location of an analyte in a biological sample using second strand synthesis
US11981960B1 (en) 2020-07-06 2024-05-14 10X Genomics, Inc. Spatial analysis utilizing degradable hydrogels
US11761038B1 (en) 2020-07-06 2023-09-19 10X Genomics, Inc. Methods for identifying a location of an RNA in a biological sample
US11981958B1 (en) 2020-08-20 2024-05-14 10X Genomics, Inc. Methods for spatial analysis using DNA capture
US11926822B1 (en) 2020-09-23 2024-03-12 10X Genomics, Inc. Three-dimensional spatial analysis
US11827935B1 (en) 2020-11-19 2023-11-28 10X Genomics, Inc. Methods for spatial analysis using rolling circle amplification and detection probes
EP4121555B1 (en) 2020-12-21 2026-02-25 10X Genomics, Inc. Methods for capturing probes and/or barcodes
EP4450641A3 (en) 2021-01-29 2024-11-13 10x Genomics, Inc. Method for transposase mediated spatial tagging and analyzing genomic dna in a biological sample
EP4428246B1 (en) 2021-04-14 2025-12-24 10X Genomics, Inc. Methods of measuring mislocalization of an analyte
EP4320271B1 (en) 2021-05-06 2025-03-19 10X Genomics, Inc. Methods for increasing resolution of spatial analysis
WO2022256503A1 (en) 2021-06-03 2022-12-08 10X Genomics, Inc. Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis
EP4196605B1 (en) 2021-09-01 2024-12-04 10X Genomics, Inc. Methods for blocking a capture probe on a spatial array
WO2023086880A1 (en) 2021-11-10 2023-05-19 10X Genomics, Inc. Methods, compositions, and kits for determining the location of an analyte in a biological sample
WO2023102118A2 (en) 2021-12-01 2023-06-08 10X Genomics, Inc. Methods, compositions, and systems for improved in situ detection of analytes and spatial analysis
WO2023172514A1 (en) 2022-03-07 2023-09-14 Catamaran Bio, Inc. Engineered immune cell therapeutics targeted to her2 and methods of use thereof
WO2023225519A1 (en) 2022-05-17 2023-11-23 10X Genomics, Inc. Modified transposons, compositions and uses thereof
US20250320487A1 (en) 2022-05-18 2025-10-16 Illumina, Inc. Preparation Of Size-Controlled Nucleic Acid Fragments
CN114774411B (zh) * 2022-06-16 2022-10-21 序康医疗科技(苏州)有限公司 大片段dna环化连接方法
JP2025521678A (ja) 2022-06-30 2025-07-10 カパ バイオシステムズ,インコーポレイティド 古細菌ヒストン様タンパク質を使用したタグメンテーション配列決定ライブラリーインサートサイズの制御
WO2024102809A1 (en) 2022-11-09 2024-05-16 10X Genomics, Inc. Methods, compositions, and kits for determining the location of multiple analytes in a biological sample
WO2025081458A1 (en) 2023-10-20 2025-04-24 Beijing Changping Laboratory Methods for reliable noninvasive preimplantation genetic testing
WO2025201494A1 (zh) * 2024-03-29 2025-10-02 苏州左旋星生物科技有限公司 一种多聚腺苷酸PolyA质粒的结构

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316946A (en) * 1987-10-05 1994-05-31 Washington University DNA transposon TN5SUPF in plasmid pBRG1310
US5925545A (en) * 1996-09-09 1999-07-20 Wisconsin Alumni Research Foundation System for in vitro transposition

Also Published As

Publication number Publication date
CA2265477C (en) 2007-03-20
JP2001507565A (ja) 2001-06-12
DE69721282D1 (de) 2003-05-28
US5925545A (en) 1999-07-20
US6437109B1 (en) 2002-08-20
CA2265477A1 (en) 1998-03-12
DE69721282T2 (de) 2003-12-18
PL332145A1 (en) 1999-08-30
AU732130B2 (en) 2001-04-12
ATE238422T1 (de) 2003-05-15
EP0927258B1 (en) 2003-04-23
CN1251135A (zh) 2000-04-19
AU4262097A (en) 1998-03-26
WO1998010077A1 (en) 1998-03-12
EP0927258A1 (en) 1999-07-07
PL193220B1 (pl) 2007-01-31
JP4361971B2 (ja) 2009-11-11
US5948622A (en) 1999-09-07
RU2218406C2 (ru) 2003-12-10
CN1163605C (zh) 2004-08-25

Similar Documents

Publication Publication Date Title
DK0973928T3 (da) DNA-baseret transposonsystem til indføring af nukleinsyre i DNA i en celle
PL332145A1 (en) System for performing in vitro transpositions
ATE225369T1 (de) Doppelsträngige peptidenukleinsäuren
EP1185546A4 (en) HIGHLY SPECIFIC PRIMERS, EXPRESSION PROCEDURES AND "KIT"
WO2005044836A3 (de) Makromolekulare nukleotidverbindungen und methoden zu deren anwendung
NO20021223D0 (no) Fremgangsmåter og sammensetninger for line¶r isoterm amplifisering av polynukleotidsekvenser
PE20010694A1 (es) Plasmido autonomamente reproducible en bacterias corineformes
DE69920477D1 (de) 2'-modifizierte oligonucleotide mit rns wirkung, die konformell eingeschränkt sind
WO2005049842A3 (en) Improved targeted dna insertion in plants
WO2004024757A3 (en) Modified pna molecules
ATE347617T1 (de) Steganographie auf dna basis
WO2001018248A3 (en) Quorum sensing signaling in bacteria
ITTO20000384A0 (it) Ruota costipatrice con ramponi sostituibili.
WO2002000871A3 (de) Verfahren zur einbringung von nukleinsäuren und anderen biologisch aktiven molekülen in der kern höherer eukaryontischer zellen mit hilfe elektrischen stroms
NO20020949D0 (no) Fettsyredesaturasegen fra planter
FR2710074B1 (fr) Gène GRB3-3, ses variants et leurs utilisations.
ES2177942T3 (es) Formulacion farmaceutica de liberacion prolongada conteniendo mizolastina.
AR010362A1 (es) UN GEN QUIMÉRICO, UN MICROORGANISMO MODIFICADO TRANSFORMADO CON EL GEN QUIMÉRICO, UN PLÁSMIDO, UN MICROORGANISMO MODIFICADO TRANSFORMADO CON EL PLÁSMIDO, MÉTODO DE MODIFICACION METABOLOLICA, MÉTODO DE PRODUCCIoN DE UNA PROTEíNA DE RAFINOSA SINTASA AISLADA Y UN ANTICUERPO ANTI-RAFINOSA SINTETASA.
BR0316224A (pt) Sequência de dna da região genÈmica tcd de photorhabdus luminescens
CO4440441A1 (es) Enzima dextranasa, metodo para su produccion y adn que la codifica
ES2000858A6 (es) Un metodo para producir un vector de expresion bacteriano para la expresion de proteinas de fusion
PE11096A1 (es) Genes que codifican el complejo o-cetoacido deshidrogenasa de cadena ramificada de streptomyces avermitilis
ES2160807T3 (es) Fragmento de adn que codifica la oxidasa de d-aminoacidos.
DK1005532T3 (da) Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf
ATE431748T1 (de) Formulierungen enthaltend dextrin polymere in kombination mit zuckern für die verabreichung von nukleinsäuren